HC Wainwright reaffirmed their neutral rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report published on Friday, Benzinga reports. CDNA has been the topic of a number of other reports. StockNews.com cut CareDx from a buy rating to a hold rating in a research note on Wednesday. Raymond James downgraded CareDx from […]